Reporters.io
George Budwell
Motley Fool
Profile
Contacts
Recent Articles on Subject
1
George Budwell
Motley Fool
Healthcare and science writer.
Houston, TX
healthcare
science
writing
1 Warren Buffett Dividend Growth Stock to Buy Right Now
- 12 days ago
An Investor's Guide to the Artificial Intelligence (AI) Value Chain
- 12 days ago
2 Disruptive Growth Stocks With Room to Run
- 18 days ago
3 Incredible Growth Stocks to Buy Right Now
- 19 days ago
Building Long-Term Wealth: Why I Chose This Vanguard Growth Fund for My Roth IRA
- 23 days ago
Are Tech Valuations Stretched to The Breaking Point? The Most Likely Answer May Surprise You
- about 2 months ago
12 High-Growth Stocks That Could Deliver Parabolic Returns
- about 2 months ago
If You Had Invested $500 in Nvidia's IPO 25 Years Ago, Here's How Much You'd Have Today
- about 2 months ago
3 Vanguard ETFs That Can Provide Lifetime Passive Income
- 2 months ago
3 Artificial Intelligence Stocks No One Is Talking About but They Should Be
- 2 months ago
3 High-Yield Dividend Stocks That Can Deliver a Lifetime of Passive Income
- 2 months ago
Get Rich Slowly: The Magic of Dividend Growth Stocks
- 3 months ago
1 Warren Buffett Stock to Hedge Against an Overheated Market
- 4 months ago
1 Dividend Growth ETF That Can Turbocharge Your Portfolio
- 4 months ago
2 Cheap Passive Income Stocks to Buy Now
- 4 months ago
Is GSK a Top Value Stock Right Now?
- 5 months ago
Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb
- 6 months ago
1 Underappreciated Reason Nvidia Stock Is a Table-Pounding Buy
- 6 months ago
Better Passive Income Vehicle: AT&T vs. JPMorgan Nasdaq Equity Premium Income ETF
- 6 months ago
10 Best Vanguard Funds to Buy Right Now
- 7 months ago
2 Ultra-High-Yield Dividend Stocks to Buy and Hold Forever
- 9 months ago
2 Incredible Growth Stocks to Buy Right Now
- 9 months ago
Better Dividend Growth Stock: AbbVie or Amgen?
- 10 months ago
2 Value Stocks With Monster Yields
- 10 months ago
Is Pfizer Stock a Buy in 2024?
- 11 months ago
3 Brilliant ETFs to Buy Right Now
- 12 months ago
2 Cathie Wood Stocks That Could Soar in 2024, According to Wall Street
- 12 months ago
Better Marijuana Stock: Aurora Cannabis or Tilray Brands?
- 12 months ago
What Is the Best Large-Cap Growth ETF to Buy Right Now?
- about 1 year ago
Better Growth Stock: Archer Aviation or Prime Medicine?
- about 1 year ago
Better Dividend Stock: Bristol Myers Squibb or Merck?
- about 1 year ago
Better Income Stock: AT&T or AbbVie?
- about 1 year ago
2 Cathie Wood Stocks That Might Be Smart Buys Right Now
- about 1 year ago
3 Vanguard ETFs That Can Serve as a Complete Portfolio
- about 1 year ago
Is ARK Innovation ETF a Top Buy Ahead of 2024?
- about 1 year ago
1 Biotech Stock That Could Be the Next Amgen
- about 1 year ago
Better Growth Stock: Vertex Pharmaceuticals or Exact Sciences?
- about 1 year ago
Better Growth Stock: Viking Therapeutics or Iovance Biotherapeutics?
- about 1 year ago
Better Growth Vehicle: Invesco QQQ Trust or Vanguard Information Technology Index Fund?
- about 1 year ago
This Diversified Portfolio Is Geared for Market-Beating Gains Over the Next 20 Years
- about 1 year ago
Why I'm Considering Selling Pfizer for Tax-Loss Harvesting Purposes
- about 1 year ago
An Important History Lesson for Gene-Editing Investors
- about 1 year ago
3 Vanguard ETFs That Are Near-Locks to Make You Richer Over Time
- about 1 year ago
1 Spectacular Dividend Stock Every Investor Should Consider
- about 1 year ago
Why Buy a Dividend Stock?
- about 1 year ago
Better Ultra-High-Yield Dividend Stock: AT&T or Altria?
- about 1 year ago
2 Biotech Stocks That Could Soar in December
- about 1 year ago
Is Pfizer Stock a Buy Ahead of This Highly Anticipated Weight Loss Readout?
- about 1 year ago
1 Dividend King That Has Quietly Outperformed This Popular Vanguard ETF
- about 1 year ago
Why Bristol Myers Squibb Stock Is Fading Today
- about 1 year ago